Opendata, web and dolomites


The first microalgae platform for the production of anticancer biopharmaceuticals

Total Cost €


EC-Contrib. €






 MABIOS project word cloud

Explore the words cloud of the MABIOS project. It provides you a very rough idea of what is the project "MABIOS" about.

overview    lower    biomanufacturing    engineered    difficult    companies    ease    limited    pharmaceutical    frontrunner    patient    enter    advantages    therapeutic    mabios    organisms    de    tumours    molecules    micro    peptides    anticancer    create    time    showcase    utilize    mission    biopharmaceutical    recombinant    living    genetically    biorefineries    manufacturing    consuming    revolutionize    obstacles    drugs    purification    unmet    treatments    start    market    yield    expensive    plan    algae    roadmap    regulatory    sold    yields    risked    patients    rate    proof    biopharmaceuticals    platform    price    works    first    scalable    lines    opportunity    investor    urgent    agents    ingredients    microalgae    business    world    solid    active    proteins    requiring    paclitaxel    drastic    oncologic    meet    treatment    demand    small    biorefinery    affordable    cancer    cultivation    line    manufacture    starting    utilizing    clear    formulate    dutch    cell    photosynthetic   

Project "MABIOS" data sheet

The following table provides information about the project.


Organization address
address: BARGELAAN 200
city: LEIDEN
postcode: 2333 CW
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MICROALGAE WORKS BV NL (LEIDEN) coordinator 50˙000.00


 Project objective

Manufacturing costs remain one of the major obstacles to providing effective treatment of cancer patients. Anticancer agents are often complex biopharmaceuticals that are expensive to manufacture, requiring use of living cell lines with difficult-to-control production processes, limited yields and time-consuming purification steps. There is an urgent unmet need for an improved manufacturing process of biopharmaceuticals, to meet the high demand and lower the price of oncologic treatments. We will revolutionize the way biopharmaceuticals are produced by developing a microalgae based biorefinery platform. These biorefineries will utilize genetically engineered microalgae to efficiently produce pharmaceutical agents. Microalgae are photosynthetic micro-organisms that have unique advantages as biopharmaceutical production systems, including high growth rate, ease of cultivation and low growth costs, enabling cost effective and scalable yield of active ingredients. These will be recombinant proteins, small molecules or therapeutic peptides, starting with Paclitaxel as showcase, one of the world’s best sold anticancer drugs used as the first line treatment of a several solid tumours. Our platform has the potential to become the new manufacturing method of choice for production of highly needed biopharmaceuticals. Microalgae Works is an ambitious Dutch start-up with the mission to make anticancer treatment affordable for every patient through a drastic reduction of manufacturing costs. We are supported by leading companies in the field of biomanufacturing. The MABIOS project will (1) create a clear overview of the market opportunity for micro-algae based production of paclitaxel, (2) develop a de-risked plan for the technical development of our platform, (3) evaluate the necessary regulatory roadmap to enter the market, and (4) formulate an investor-proof business plan. We aim to become the frontrunner in biopharmaceutical production utilizing microalgae.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MABIOS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MABIOS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

LTS (2020)


Read More  

EVERCAM (2020)

Intelligent Vision System for Improved Communication and Higher Productivity in Construction

Read More  

VACTEC (2019)

VACTEC_Responsive corrosion inhibiting Vacuum Technology-based fire protection system

Read More